Case Report: Life-Threatening Fluoxetine-Linked Postoperative Bleeding Informed by Pharmacogenetic Evaluation
Open Access
- 28 February 2024
- journal article
- case report
- Published by Springer Nature in Drugs in R&D
- Vol. 24 (1) , 117-121
Abstract
Background Selective serotonin reuptake inhibitors (SSRI) are commonly used for the treatment of depression and anxiety. Inhibition of serotonin reuptake in platelets increases bleeding risk in patients taking SSRIs. Case Here, we present the case of a 52-year-old patient who developed severe postsurgical bleeding requiring blood transfusion following panniculectomy. Conclusion SSRI-induced bleeding is dose-related and strongly influenced by individual variations in drug metabolizing enzymes and transporters. Video abstract Supplementary file1 (MP4 8441 KB)Keywords
This publication has 14 references indexed in Scilit:
- Demonstration of an action pathway in mouse platelets leading to prolongation of bleeding time by fluoxetineEuropean Journal of Pharmacology, 2020
- Fluoxetine and Risk of Bleeding in Patients Aged 60 Years and Older Using the Korea Adverse Event Reporting System DatabaseJournal of Clinical Psychopharmacology, 2019
- Platelet biology and functions: new concepts and clinical perspectivesNature Reviews Cardiology, 2018
- Clinical Management of Bleeding Risk With AntidepressantsAnnals of Pharmacotherapy, 2018
- Selective Serotonin Reuptake Inhibitors and Operative Bleeding RiskJournal of Clinical Psychopharmacology, 2016
- Influence of pre‐operative use of serotonergic antidepressants (SADs) on the risk of bleeding in patients undergoing different surgical interventions: a meta‐analysisPharmacoepidemiology and Drug Safety, 2014
- Perioperative Use of Selective Serotonin Reuptake Inhibitors and Risks for Adverse Outcomes of SurgeryJAMA Internal Medicine, 2013
- CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendantsPharmacogenomics, 2002
- Pharmacokinetics of Selective Serotonin Reuptake Inhibitors: Clinical RelevanceBasic & Clinical Pharmacology & Toxicology, 1996
- Fluoxetine, a selective inhibitor of serotonin uptakeMedicinal Research Reviews, 1991